ascopubs.org/doi/10.1200/OP…

Who do you want on a work group revising the definition of #Alzheimer’s disease? The system is broken when Pharma and diagnostic companies are the ones defining who is sick. The National Institute on Aging (NIA) knew this when NIH told them to take their name off the workgroup title journals.lww.com/neurotodayonli…

💻American Cancer Society & CAPC Webinar 'Empowering Patients in Shared Decision-Making: The State of the Science in Palliative Care for Oncology ' 9/10 🔗 bit.ly/3YmySjD Open to all, register on the ACS website.

🤩Thrilled to represent🚂The START Center & be a part of this webinar with Melanoma Research Dana Deighton and🎯TargetCancer Fdn🧬about rare🦓cancers - Looking forward to an engaging discussionRegister and submit your questions now! lnkd.in/eyCcmU-U

We are hiring! Consider applying to join our hematology oncology division Zuckerberg SF General Hospital & Trauma Center UCSF Helen Diller Family Comprehensive Cancer Ctr ! Institution with rich history, diversity, and mission, as well as wonderful colleagues Terry Friedlander NiharikaDixit Becky DeBoer Adnan Alseidi

¡Día Nacional de los Médicos Latinos! Primero de Octubre Thank you M. Loeza, MD, MPH for your amazing NLPD art!! Order your merch at shorturl.at/uefJ8and check out nationallatinophysicianday.com #nationallatinophysicianday #nationallatinaphysicianday #nationallatinxphysicianday

A treasure of a read. Great advice for researchers of all kinds. #WCLC24 #lcsm IASLC ASCO TECAG ASCO ASCO OncMedEdCoP Hem-Onc Fellows Network

The Early Career Investigator Workshop is on 🔥🔥🔥. So much great advice being presented here! IASLC #WCLC24 #lcsm ASCO TECAG ASCO OncMedEdCoP

Tons of excitement & new ideas from IASLC Communications Committee! Join us now at 26B for the #WCLC24 Communication Workshop

With pleasure. Thank you Fernando Diaz, MD! Are you here IASLC #WCLC? I’m just hanging my poster!

The Bergerots 🤩🤩 Power couple of #WCLC24 Paulo G Bergerot presented their remarkable research today with a poster presentation. This pilot study on exercise for lung cancer patients revealed notable improvements in both quality of life & symptom relief. Check out the poster 💯

🔥HOT OFF THE🗞️PRESS in npj Journals w/ Johns Hopkins Kimmel Cancer Center "Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia"‼️ Astellas Pharma US Gilteritinib is a POTENT💊ALK inhibitor and inv(2)🧬creates constitutively active ALK😲‼️bit.ly/3AZlvfw

CanNOT overstate the life changing role of palliative care - but it continues to be underutilized. Thank you Laura Petrillo 🗽 for dispelling the myths and emphasizing the need of early intervention! #WCLC24

"Imagine walking into a fancy restaurant only to find a menu consisting mostly of kids’ dishes. It would make no sense. Just 25% of restaurant diners are younger than age 12, and they rarely write Yelp reviews. But when it comes to cancer treatment, this is not very far from

Written with Bobby Green Julia Frydman we make some commonsense interventions for Older Adults w/Cancer (1) Geriatric Assessment (2) Proactive Monitoring (3) Dose-Adjustment when appropriate (4) Consider Palliative Care (5) Outcome prioritization

"As doctors, we are sworn to offer the best possible care we can to all our patients. And, as cancer care specialists treating older adults, we must ensure this care is not too much nor too little but personalized care that is just right" cc: William Dale, MD, PhD, FASCO Supriya Mohile

A day late, but thanks to Rachna Shroff, MD, MS, FASCO for a brilliant and inspiring lecture honoring Dr. Varadhachary. The best questions truly do come from clinic. And I ask myself often, “what would Dr. V do?” MD Anderson Cancer Center

My insights about #EMERALD study. Patients who progressed < 12m vs > 12m of iCDK Thanks OncoDaily for this open space. oncodaily.com/insight/141044